Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer

Anhui Medical University · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
pcaprostatecancer
mrd, prostate cancer, mhspc, minimal residual disease, pca, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 889254
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.